Business Pfizer buys firm with cannabinoid therapy in clinical trial Olorinab is a CB2 receptor agonist in a Phase 2 trial for IBS Nick LabaDecember 15, 2021
Business Canopy selling German subsidiary for up to $180M, losing nearly half of purchase price The company bought the German firm for $325M in 2019 Nick LabaDecember 15, 2021
Business Numinus to start trading on TSX The firm will celebrate by ringing the opening bell at the stock exchange on Thursday Kathryn TindaleDecember 15, 2021
Business Fire & Flower ups sales 6% to $45M in Q3, offset by surge of new Ontario stores Pot shop openings in the province rose rose by 27% in the quarter Natalia Buendia CalvilloDecember 14, 2021
Business Hexo’s sales spike 31% with $117M loss after steep impairments in Q1 The company is also making a number of new changes to its top management Nick LabaDecember 14, 2021
Business Curaleaf to raise US$425M from private placement The firm says the low interest rate will allow it to refinance its debt Nick LabaDecember 13, 2021
Business Fire & Flower to get up to $30M in loans from Circle K owner Some of the funds will go toward expanding its digital retail platform Nick LabaDecember 13, 2021
Business Cresco Labs closes US$80M acquisition of Pennsylvania operator Another potential bill to legalize adult-use in the state was introduced in September Nick LabaDecember 10, 2021
Business Numinus ends fiscal year with revenue up 72% to $1.5M, losses of $19M The psychedelics firm has been aggressively expanding lab space while pushing ahead with clinical trials Natalia Buendia CalvilloDecember 10, 2021
Business Fire & Flower to buy Pineapple Express Delivery The firm will pay for the deal by repaying about $5.3 million of Pineapple Express's debt and issuing about 1,126,761 shares Kathryn TindaleDecember 9, 2021